Cargando…
Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia
Many patients with chronic lymphocytic leukemia (CLL) experience physical dysfunction and low overall fitness. It remains unknown what factors drive CLL physical dysfunction. We assessed physical function and metabolic lipoprotein panels in 106 patients with CLL. In univariate analyses of clinical f...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381973/ https://www.ncbi.nlm.nih.gov/pubmed/35992862 http://dx.doi.org/10.3389/fonc.2022.933619 |
_version_ | 1784769196223102976 |
---|---|
author | Sitlinger, Andrea Deal, Michael A. Garcia, Erwin Connelly, Margery Thompson, Dana Stewart, Tiffany Macdonald, Grace Hanson, Erik D. Neely, Megan Neely, Ben Artese, Ashley Weinberg, J. Brice Brander, Danielle Bartlett, David B. |
author_facet | Sitlinger, Andrea Deal, Michael A. Garcia, Erwin Connelly, Margery Thompson, Dana Stewart, Tiffany Macdonald, Grace Hanson, Erik D. Neely, Megan Neely, Ben Artese, Ashley Weinberg, J. Brice Brander, Danielle Bartlett, David B. |
author_sort | Sitlinger, Andrea |
collection | PubMed |
description | Many patients with chronic lymphocytic leukemia (CLL) experience physical dysfunction and low overall fitness. It remains unknown what factors drive CLL physical dysfunction. We assessed physical function and metabolic lipoprotein panels in 106 patients with CLL. In univariate analyses of clinical factors, a longer time since diagnosis was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 3.56, 95% CI: 1.37–9.22; p = 0.002) and physical performance (SPPB: OR = 2.03, 95% CI: 1.20–3.44; p = 0.004). Having received treatment was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 1.57, 95% CI: 1.02–2.40; p = 0.036), SPPB (OR = 1.85, 95% CI: 1.13–3.03; p = 0.011) and grip strength (OR = 1.67, 95% CI: 1.10–2.55; p = 0.015). We found that several small HDL particle parameters, higher levels of citrate (OR = 2.01, 95% CI: 1.22–3.31; p = 0.030), and lower levels of hemoglobin (OR = 0.50, 95% CI: 0.31–0.82; p = 0.030) were associated with a higher likelihood of dysfunctional aerobic fitness. Multivariable least absolute shrinkage and selection operator (LASSO)-penalized regression analyses using variable importance measures (VIM) showed that 7.8-nm HDL particles (VIM = 1.000) and total HDL particle levels (VIM = 1.000) were more informative than clinical measures for the odds of dysfunctional aerobic fitness and 6-min walk functional fitness, respectively, while 10.3-nm HDL particles (VIM = 0.383) were more informative for grip strength. Time since diagnosis (VIM = 0.680) and having received treatment (VIM = 0.490) were more informative than lipoprotein measures for the odds of having dysfunctional SPPB. Taken together, we establish significant relationships between clinical and metabolic factors and physical characteristics that might prompt early use of ancillary support services. |
format | Online Article Text |
id | pubmed-9381973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93819732022-08-18 Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia Sitlinger, Andrea Deal, Michael A. Garcia, Erwin Connelly, Margery Thompson, Dana Stewart, Tiffany Macdonald, Grace Hanson, Erik D. Neely, Megan Neely, Ben Artese, Ashley Weinberg, J. Brice Brander, Danielle Bartlett, David B. Front Oncol Oncology Many patients with chronic lymphocytic leukemia (CLL) experience physical dysfunction and low overall fitness. It remains unknown what factors drive CLL physical dysfunction. We assessed physical function and metabolic lipoprotein panels in 106 patients with CLL. In univariate analyses of clinical factors, a longer time since diagnosis was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 3.56, 95% CI: 1.37–9.22; p = 0.002) and physical performance (SPPB: OR = 2.03, 95% CI: 1.20–3.44; p = 0.004). Having received treatment was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 1.57, 95% CI: 1.02–2.40; p = 0.036), SPPB (OR = 1.85, 95% CI: 1.13–3.03; p = 0.011) and grip strength (OR = 1.67, 95% CI: 1.10–2.55; p = 0.015). We found that several small HDL particle parameters, higher levels of citrate (OR = 2.01, 95% CI: 1.22–3.31; p = 0.030), and lower levels of hemoglobin (OR = 0.50, 95% CI: 0.31–0.82; p = 0.030) were associated with a higher likelihood of dysfunctional aerobic fitness. Multivariable least absolute shrinkage and selection operator (LASSO)-penalized regression analyses using variable importance measures (VIM) showed that 7.8-nm HDL particles (VIM = 1.000) and total HDL particle levels (VIM = 1.000) were more informative than clinical measures for the odds of dysfunctional aerobic fitness and 6-min walk functional fitness, respectively, while 10.3-nm HDL particles (VIM = 0.383) were more informative for grip strength. Time since diagnosis (VIM = 0.680) and having received treatment (VIM = 0.490) were more informative than lipoprotein measures for the odds of having dysfunctional SPPB. Taken together, we establish significant relationships between clinical and metabolic factors and physical characteristics that might prompt early use of ancillary support services. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9381973/ /pubmed/35992862 http://dx.doi.org/10.3389/fonc.2022.933619 Text en Copyright © 2022 Sitlinger, Deal, Garcia, Connelly, Thompson, Stewart, Macdonald, Hanson, Neely, Neely, Artese, Weinberg, Brander and Bartlett https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Sitlinger, Andrea Deal, Michael A. Garcia, Erwin Connelly, Margery Thompson, Dana Stewart, Tiffany Macdonald, Grace Hanson, Erik D. Neely, Megan Neely, Ben Artese, Ashley Weinberg, J. Brice Brander, Danielle Bartlett, David B. Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title | Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title_full | Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title_fullStr | Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title_full_unstemmed | Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title_short | Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
title_sort | associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381973/ https://www.ncbi.nlm.nih.gov/pubmed/35992862 http://dx.doi.org/10.3389/fonc.2022.933619 |
work_keys_str_mv | AT sitlingerandrea associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT dealmichaela associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT garciaerwin associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT connellymargery associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT thompsondana associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT stewarttiffany associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT macdonaldgrace associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT hansonerikd associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT neelymegan associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT neelyben associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT arteseashley associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT weinbergjbrice associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT branderdanielle associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia AT bartlettdavidb associationsofclinicalandcirculatingmetabolicbiomarkerswithlowphysicalfitnessandfunctioninadultswithchroniclymphocyticleukemia |